Short description
Precision BioSciences is a biotechnology company dedicated to improving life.
Description
Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS.
Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Durham, North Carolina, United States, North America
Founded on
January 1, 2006
Exited on
March 27, 2019
Went public on
March 27, 2019
Stock symbol
DTIL
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$56378 - 90123
Sign in for full access
Investors
Cannot Access, Noaccess, Noaccessforu, No Way, No Way, Absolutely Noaccess, Blurry Noaccess, Noaccess, Noaccessforu, Nopepepe, Cannot Access, Noaccessforu, Noway Youcantaccess, Nopepepe, Uh Ohhhh, Nopepepe, Blurry Noaccess, Absolutely Noaccess, Blurry Noaccess, Absolutely Noaccess, Noaccess, No Way, Noaccess, Nopepepe, Nopepepe, Noaccess, Absolutely Noaccess, Cannot Access, Absolutely Noaccess, Blurry Noaccess
Sign in for full access
Founders
Derek Jantz, Jeff Smith, Matthew Kane